NCT01408355View on ClinicalTrials.gov

A Study To Investigate The Elimination Of PF-06273588 From The Body Following A Single Low Dose.

PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions
Healthy Volunteers
Interventions
DRUG

PF-06273588

Intravenous, 50 microgram, single dose

DRUG

PF-06273588

Oral solution, 50 microgram, single dose

Trial Locations (1)

NG11 6JS

Pfizer Investigational Site, Ruddington Fields

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01408355 - A Study To Investigate The Elimination Of PF-06273588 From The Body Following A Single Low Dose. | Biotech Hunter | Biotech Hunter